EDBI
Singapore's Doctor Anywhere raises $38m, makes acquisition
Southeast Asia-focused telehealth platform Doctor Anywhere has closed a second tranche of Series C funding worth USD 38.8m and acquired Singapore-listed Asian Healthcare Specialists (AHS).
CEO of Singapore's EDBI departs to launch own fund
Swee Yeok Chu, CEO and president of Singapore government investor EDBI, is stepping down from her role with a view to launching her own fund.
Indonesia’s Fazz raises $100m Series C
Indonesia’s Fazz, a financial services provider for Southeast Asia micro businesses, has raised a USD 100m Series C round featuring Tiger Global, DST Global, and B Capital Group.
Deal focus: Singapore biotech start-up generates US buzz
Singapore’s Tessa Therapeutics has developed a cancer drug that appears to be twice as effective as other treatments in its class. It has raised USD 126m with eyes on a near-term US IPO
Singapore cancer treatment start-up gets $126m Series A
Singapore’s Tessa Therapeutics, a biotech developer with a Hodgkin's lymphoma treatment in phase-two trials, has raised a USD 126m Series A round led by US healthcare specialist Polaris Partners.
Singapore's Neuron Mobility gets $43.5m
Singapore-based e-scooter rental start-up Neuron Mobility has raised USD 43.5m in Series B funding co-led by GSR Ventures and Square Peg Capital.
Singapore mRNA vaccine developer raises $140m
RVAC Medicines, a Singapore-based company involved in developing messenger RNA (mRNA) vaccines for COVID-19, has closed a Series B round that takes its overall funding to USD 140m.
Deal focus: Faux fowl fast-forwards
Next Gen Foods is pushing hard to popularise its meatless chicken brand Tindle in the name of climate action. The largest-ever Series A round in alternative protein is jumpstarting the campaign
Deal focus: Affirma sees promise in Asia e-scooters
Affirma Capital has led a USD 93m Series B round for Singapore-based e-scooter provider Beam, citing its ability to internationalise a locally-focused and increasingly popular business model
Vision Fund leads $144m round for Singapore lending platform
SoftBank Vision Fund 2 has led a USD 144m equity round for Singapore small business lending platform Funding Societies.
Singapore's Next Gen Foods raises $100m Series A
Singapore-based Next Gen Foods, maker of vegetarian chicken brand Tindle, has raised a USD 100m Series A round featuring GGV Capital and Temasek Holdings’ Asia Sustainable Foods Platform.
Deal focus: Quiet confidence persists in hydrogen power
H3 Dynamics is bringing hydrogen-powered delivery drones to Asia’s crammed megacities as a steppingstone to a cleaner aviation sector. This is a sweet spot for Hong Kong’s Audacy Ventures
Singapore drone services player gets $26m Series B
H3 Dynamics, a Singapore-based autonomous drone data services and hydrogen air logistics start-up, has raised a $26 million Series B round led by Japan’s Sparx Asset Management.
Pacific Century’s insurtech business extends Series A to $210m
Pacific Century Group’s insurance technology business, Bolttech, has extended a recent $180 million Series A round to $210 million in total.
SoftBank, Warburg Pincus back Singapore's Advanced Intelligence
Advance Intelligence Group, a Singapore start-up best known for digital identity verification and fraud prevention platform Advance.AI and buy now, pay later (BNPL) business Atome, has raised over $400 million in Series D funding.
Singapore plans pre-IPO fund to attract listings
Singapore’s EDB Investments (EDBI) will establish a pre-IPO fund – with an initial commitment of S$500 million ($370 million) – that is intended to encourage high-growth companies to list in the city-state.
Deal focus: Singapore's Doctor Anywhere raises $65m Series C
Doctor Anywhere’s omnichannel approach to digitizing Southeast Asian healthcare is luring investors with eyes on the pandemic’s most logical trend. Preserving a first-mover advantage is the challenge
Deal focus: GA backs VNLife’s two-pronged fintech play
VNLife is not alone in trying to build value-added services onto a payment platform in Vietnam, but it is unusual in being able to rely on a profitable B2B digital banking business while figuring out monetization
GA, Dragoneer lead $250m Series B for Vietnam's VNLife
General Atlantic and Dragoneer Investment Group have led a $250 million Series B round for Vietnamese financial technology provider VNLife.
Singapore gene therapy start-up closes $24m Series A
Nuevocor, a preclinical biotech company specializing in gene therapy for heart disease, has closed an oversubscribed Series A round with $24 million in commitments.
Singapore biotech start-up closes $125m Series C
Novo Holdings, which manages the wealth of Denmark’s Novo Nordisk Foundation, has led a $125 million Series C round for Hummingbird Bioscience, a Singapore and US-based drug developer.
Deal focus: Cityneon proves the show must go on
Singapore’s Cityneon has seen a robust rebound in its live events business, driven primarily by China. The company now has $177 million in new funding and deals covering everything from ancient Egypt to Avatar
Pavilion joins $177m round for Singapore's Cityneon
Pavilion Capital has joined a S$235 million ($177 million) round for Singapore’s Cityneon, a company that markets entertainment brands by staging elaborate events, displays, and exhibitions.
Southeast Asia start-ups: Trials of leadership
COVID-19 has forced start-ups founders in Southeast Asia – many of whom have never experienced a crisis before – to make tough decisions. For investors, it represents a key test of management credentials
